Imfinzi

US FDA approves AstraZeneca’s non-small cell lung cancer treatment

Read more

Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData

Read more

AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer

Read more

China approves Imfinzi to treat small cell lung cancer

Read more

EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer

Read more

AstraZeneca’s Imfinzi gets FDA priority review for small cell lung cancer

Read more